Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online May 31, 2007
Stem Cells Vol. 25 No. 9 September 2007, pp. 2363 -2370
doi:10.1634/stemcells.2006-0686; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2006-0686v1
25/9/2363    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hung, S.-C.
Right arrow Articles by Prockop, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hung, S.-C.
Right arrow Articles by Prockop, D. J.

TRANSLATIONAL AND CLINICAL RESEARCH: MESENCHYMAL STEM CELLS SERIES

Angiogenic Effects of Human Multipotent Stromal Cell Conditioned Medium Activate the PI3K-Akt Pathway in Hypoxic Endothelial Cells to Inhibit Apoptosis, Increase Survival, and Stimulate Angiogenesis

Shih-Chieh Hunga,b,c, Radhika R. Pochampallya, Sy-Chi Chenb, Shu-Ching Hsua, Darwin J. Prockopa

aCenter for Gene Therapy, Tulane University Health Science Center, New Orleans, Louisiana, USA;
bStem Cell Laboratory, Veterans General Hospital-Taipei, Taipei, Taiwan;
cInstitute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

Key Words. Bone marrow stromal cells • Hypoxia • Endothelial cell • Angiogenesis • Apoptosis • Human aortic endothelial cells Interleukin-6 • Therapeutic potential

Correspondence: Darwin J. Prockop, Ph.D., M.D., Center for Gene Therapy, Tulane University Health Sciences Center, 1430 Tulane Avenue, SL-99, New Orleans, Louisiana 70112, USA. Telephone: (504) 988-7711; Fax: (504) 988-7710; e-mail: dprocko{at}tulane.edu; or Shih-Chieh Hung, Ph.D., M.D., Department of Medical Research and Education, Veteran General Hospital-Taipei, 201, Sec2, Shih-Pai Road, Taipei, Taiwan. Telephone: 886-2-28757396; Fax: 886-2-28757396; e-mail: hungsc{at}vghtpe.gov.tw

Received on October 26, 2006; accepted for publication on May 18, 2007.

First published online in STEM CELLS EXPRESS  May 31, 2007.


Recent reports indicated that vascular remodeling and angiogenesis are promoted by conditioned medium from the cells referred to as multipotent stromal cells (MSCs). However, the molecular events triggered by MSC-conditioned medium (CdM) were not defined. We examined the effects of CdM from human MSCs on cultures of primary human aortic endothelial cells (HAECs). The CdM inhibited hypoxia-induced apoptosis and cell death of HAECs. It also promoted tube formation by HAECs in an assay in vitro. Conditioned medium from multipotent stromal cells incubated under hypoxic conditions in serum-free endothelial basal medium for 2 days (CdMHyp) from hypoxic culture of MSCs was more effective than conditioned medium from MSCs incubated under normoxic conditions in serum-free endothelial basal medium for 2 days from normoxic cultures of MSCs, an observation in part explained by its higher content of antiapoptotic and angiogenic factors, such as interleukin (IL)-6, vascular endothelial growth factor (VEGF), and monocyte chemoattractant protein (MCP)-1. The effects of CdMHyp on hypoxic HAECs were partially duplicated by the addition of IL-6 in a dose-dependent manner; however, anti-IL-6, anti-MCP-1, and anti-VEGF blocking antibodies added independently did not attenuate the effects. Also, addition of CdMHyp activated the PI3K-Akt pathway; the levels of p-Akt and several of its downstream targets were increased by CdMHyp, and both the increase in p-Akt and the increase in angiogenesis were blocked by an inhibitor of PI3K-Akt or by expression of a dominant negative gene for PI3K. CdMHyp also increased the levels of p-extracellular signal-regulated kinase (ERK), but there was a minimal effect on p-signal transducer and activator of transcription-3, and an inhibitor of the ERK1/2 pathway had no effect on hypoxia-induced apoptosis of the HAECs. The results are consistent with suggestions that administration of MSCs or factors secreted by MSCs may provide a therapeutic method of decreasing apoptosis and enhancing angiogenesis.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
BloodHome page
B. J. Capoccia, D. L. Robson, K. D. Levac, D. J. Maxwell, S. A. Hohm, M. J. Neelamkavil, G. I. Bell, A. Xenocostas, D. C. Link, D. Piwnica-Worms, et al.
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity
Blood, May 21, 2009; 113(21): 5340 - 5351.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
G. J. Block, S. Ohkouchi, F. Fung, J. Frenkel, C. Gregory, R. Pochampally, G. DiMattia, D. E. Sullivan, and D. J. Prockop
Multipotent Stromal Cells Are Activated to Reduce Apoptosis in Part by Upregulation and Secretion of Stanniocalcin-1
Stem Cells, March 1, 2009; 27(3): 670 - 681.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Rafei, J. Hsieh, S. Fortier, M. Li, S. Yuan, E. Birman, K. Forner, M.-N. Boivin, K. Doody, M. Tremblay, et al.
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction
Blood, December 15, 2008; 112(13): 4991 - 4998.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
P. Dufourcq, B. Descamps, N. F. Tojais, L. Leroux, P. Oses, D. Daret, C. Moreau, J.-M. D. Lamaziere, T. Couffinhal, and C. Duplaa
Secreted Frizzled-Related Protein-1 Enhances Mesenchymal Stem Cell Function in Angiogenesis and Contributes to Neovessel Maturation
Stem Cells, November 1, 2008; 26(11): 2991 - 3001.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Morigi, M. Introna, B. Imberti, D. Corna, M. Abbate, C. Rota, D. Rottoli, A. Benigni, N. Perico, C. Zoja, et al.
Human Bone Marrow Mesenchymal Stem Cells Accelerate Recovery of Acute Renal Injury and Prolong Survival in Mice
Stem Cells, August 1, 2008; 26(8): 2075 - 2082.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
I. Rosova, M. Dao, B. Capoccia, D. Link, and J. A. Nolta
Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells
Stem Cells, August 1, 2008; 26(8): 2173 - 2182.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. G. Phinney and D. J. Prockop
Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair Current Views
Stem Cells, November 1, 2007; 25(11): 2896 - 2902.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2007 by AlphaMed Press.